Evidence map›Paper›PMID 42306053›Full record

ArticleJTCVS structural and endovascular2025

Comparative midterm results of surgical mitral valve replacement and transcatheter mitral valve replacement with the Tendyne System.

Andrea Colli, Cristina Di Franco, Federico Giorgi, Giosuè Falcetta, Danilo Ruggiero, Michele Celiento, Giacomo Ravenni, Riccardo Morganti, Laura Besola

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JTCVS structural and endovascular, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrea ColliCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Cristina Di FrancoCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Federico GiorgiCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Giosuè FalcettaCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Danilo RuggieroCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Michele CelientoCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Giacomo RavenniCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.
Riccardo MorgantiBiostatistics Unit, Pisa University Hospital, Pisa, Italy.
Laura BesolaCardiac Surgery Division, and Department of Surgical, Medical and Molecular Pathology and Critical Care, University of Pisa, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To compare the midterm clinical and echocardiographic outcomes of high-risk patients who underwent surgical mitral valve replacement (SMVR) or transcatheter mitral valve replacement (TMVR) with the Tendyne System in a single-center setting. Methods: The study included all consecutive high-risk patients who underwent TMVR or SMVR at the University of Pisa, Pisa, Italy, between March 2018 and December 2023. The primary outcome was cardiovascular (CV) mortality at follow-up (FU), whereas secondary outcomes were overall mortality and rehospitalization for heart failure at FU. Results: We included 30 patients who underwent TMVR and 50 who underwent SMVR. Although the European System for Cardiac Operative Risk Evaluation II and Society of Thoracic Surgeons scores were similar, patients who underwent TMVR were older and had worse renal function and left ventricular ejection fraction (LVEF, 41.80 ± 13% and 56.89 ± 10.23%). The 30-day CV mortality was lower in the TMVR group ( Conclusions: SMVR and TMVR showed similar early and midterm clinical and echocardiographic outcomes in a high-risk population. However, TMVR resulted in a lower postoperative complication rate and faster recovery. Therefore, TMVR might be a possible alternative to surgery for selected high-risk patients.

Indexed as

mitral valve diseaseSMVRTendyneTMVR

Identifiers

PMID42306053
PMCPMC13244705

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.